TABLE 3.
Selected clinicopathologic variables compared between success and failure groups in cats.
| Factor studied | Outcome (n = number of patients with available data) | Median value of studied factor (range: min‐max) | Number of patients presenting studied factor (%) | P value | |
|---|---|---|---|---|---|
| Clinicopathologic variables at admission | Age (years old) | Success (n = 20) | 4 (1‐15) | NA | .01 |
| Failure (n = 39) | 8.5 (3‐17) | ||||
| Weight (kg) | Success (n = 20) | 4.17 (2.9‐7.3) | NA | .94 | |
| Failure (n = 39) | 3.7 (2.35‐9.55) | ||||
| Sex | Success (n = 20) | NA | 9 spayed females, 1 intact female, and 11 neutered males | .4 | |
| Failure (n = 39) | 24 spayed females and 15 neutered males | ||||
| Hct (%) | Success (n = 18) | 32.5 (25‐56) | NA | .14 | |
| Failure (n = 35) | 32 (19‐47) | ||||
| Serum creatinine (mg/dL) | Success (n = 20) | 4.7 (1.4‐21.3) | NA | .34 | |
| Failure (n = 39) | 3.8 (1.7‐17.5) | ||||
| Urea (mg/dL) | Success (n = 16) | 62.7 (18.8‐206.5) | NA | .72 | |
| Failure (n = 32) | 66.1 (26.9‐180.1) | ||||
| Bicarbonates | Success (n = 19) | 18 (9.2‐24.4) | NA | .32 | |
| Failure (n = 37) | 17.8 (8.70‐32.3) | ||||
| pH | Success (n = 11) | 7.32 (7.196‐7.416) | NA | .9 | |
| Failure (n = 16) | 7.335 (7.13‐7.45) | ||||
| Phosphorus (mg/dL) | Success (n = 16) | 6.0 (3.4‐19.8) | NA | .31 | |
| Failure (n = 33) | 5.2 (2.2‐16) | ||||
| Potassium (mmol/L) | Success (n = 20) | 4.39 (2.5‐6.12) | NA | .32 | |
| Failure (n = 39) | 4.2 (1.8‐5.9) | ||||
| Positive culture | Success (n = 16) | NA | 1 (6%) | .17 | |
| Failure (n = 34) | 8 (23%) | ||||
| Clinical variables at 24 h after admission | Serum creatinine concentration (mg/dL) | Success (n = 16) | 4.9 (1.4‐15) | NA | .51 |
| Failure (n = 27) | 5 (1.5‐15) | ||||
| Serum potassium concentration (mmol/L) | Success (n = 16) | 3.95 (2.9‐7.9) | NA | .96 | |
| Failure (n = 26) | 3.95 (2.9‐6.2) | ||||
| Blood pH | Success (n = 8) | 7.3825 (7.264‐7.46) | NA | .36 | |
| Failure (n = 18) | 7.37 (6.997‐7.449) | ||||
| Blood bicarbonate concentration | Success (n = 12) | 16.95 (11.8‐30.8) | NA | .71 | |
| Failure (n = 19) | 17.8 (8.2‐23.7) | ||||
| Clinical variables at 48 h after admission | Serum creatinine (mg/dL) | Success (n = 14) | 4.1 (1.4‐15) | NA | .72 |
| Failure (n = 29) | 4 (1.6‐15) | ||||
| Potassium (mmol/L) | Success (n = 13) | 4 (3.2‐5) | NA | .11 | |
| Failure (n = 27) | 4.24 (3.03‐7.5) | ||||
| pH | Success (n = 8) | 7.4155 (7.238‐7.48) | NA | .17 | |
| Failure (n = 16) | 7.35 (6.97‐7.443) | ||||
| Bicarbonates —HCO3 − | Success (n = 10) | 19.3 (13.5‐28) | NA | .27 | |
| Failure (n = 21) | 19.4 (7.7‐22.6) | ||||
| Treatment | Prazosin | Success (n = 20) | NA | 18 (90%) | .57 |
| Failure (n = 39) | 33 (84%) | ||||
| Amitryptiline | Success (n = 20) | NA | 0 | .99 | |
| Failure (n = 39) | 2 (5%) | ||||
| Corticosteroids | Success (n = 20) | NA | 8 (40%) | .26 | |
| Failure (n = 39) | 9 (23%) | ||||
| Furosemide | Success (n = 20) | NA | 4 (20%) | .32 | |
| Failure (n = 39) | 12 (31%) | ||||
| Mannitol | Success (n = 20) | NA | 2 (10%) | .57 | |
| Failure (n = 39) | 6 (15%) | ||||
| Analgesia | Success (n = 20) | NA | 13 (65%) | .95 | |
| Failure (n = 39) | 25 (64%) | ||||
| Hospitalization and IV fluids | Success (n = 20) | NA | 17 (85%) | .97 | |
| Failure (n = 39) | 33 (85%) | ||||
| Complication during hospitalization | Oligo‐anuria | Success (n = 20) | NA | 3 (15%) | .11 |
| Failure (n = 39) | 1 (3%) | ||||
| Volume overload | Success (n = 20) | NA | 2 (10%) | .24 | |
| Failure (n = 39) | 9 (23%) | ||||
| Characteristics of obstruction | Bilateral vs unilateral | Success (n = 20) | NA |
15 unilateral (75%) 5 bilateral (25%) |
.12 |
| Failure (n = 39) | NA |
21 unilateral (54%) 18 bilateral (46%) |
|||
Note: P < .05 is considered significant. Bold values represent statistically significant results.
Abbreviation: NA, not applicable.